Insider Transactions in Q4 2023 at Hologic Inc (HOLX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 13
2023
|
Peter Paul Dunne SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,231
+10.37%
|
-
|
|
Dec 11
2023
|
Scott T Garrett Director |
SELL
Open market or private sale
|
Direct |
10,000
-17.53%
|
$680,000
$68.71 P/Share
|
|
Nov 29
2023
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Open market or private sale
|
Direct |
47,711
-3.71%
|
$3,339,770
$70.41 P/Share
|
|
Nov 29
2023
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
47,711
+3.58%
|
$1,240,486
$26.21 P/Share
|
|
Nov 21
2023
|
Essex D Mitchell Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,500
-36.9%
|
$532,500
$71.85 P/Share
|
|
Nov 14
2023
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,687
+6.81%
|
-
|
|
Nov 14
2023
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,832
+3.19%
|
-
|
|
Nov 14
2023
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,687
+29.94%
|
-
|
|
Nov 14
2023
|
Jennifer M Schneiders President, Diag. Solutions |
BUY
Grant, award, or other acquisition
|
Direct |
3,475
+35.42%
|
-
|
|
Nov 14
2023
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
6,950
+7.49%
|
-
|
|
Nov 14
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,216
+7.4%
|
-
|
|
Nov 14
2023
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
6,950
+4.01%
|
-
|
|
Nov 14
2023
|
Elisabeth A Hellmann SVP, Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
1,390
+12.68%
|
-
|
|
Nov 14
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
3,822
+18.82%
|
-
|
|
Nov 09
2023
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
65,811
-5.21%
|
$4,409,337
$67.2 P/Share
|
|
Nov 09
2023
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
1,478
-1.84%
|
$99,026
$67.2 P/Share
|
|
Nov 09
2023
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,899
-9.0%
|
$730,233
$67.2 P/Share
|
|
Nov 09
2023
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,300
-16.5%
|
$154,100
$67.2 P/Share
|
|
Nov 09
2023
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-5.73%
|
$11,658
$67.2 P/Share
|
|
Nov 09
2023
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
9,375
-5.55%
|
$628,125
$67.2 P/Share
|
|
Nov 09
2023
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-2.32%
|
$12,998
$67.2 P/Share
|
|
Nov 09
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217
-1.53%
|
$14,539
$67.2 P/Share
|
|
Nov 09
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
1,439
-10.2%
|
$96,413
$67.2 P/Share
|
|
Nov 08
2023
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,442
-0.43%
|
$370,056
$68.27 P/Share
|
|
Nov 08
2023
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
194
-0.24%
|
$13,192
$68.27 P/Share
|
|
Nov 08
2023
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
688
-0.57%
|
$46,784
$68.27 P/Share
|
|
Nov 08
2023
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
335
-2.35%
|
$22,780
$68.27 P/Share
|
|
Nov 08
2023
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
121
-3.83%
|
$8,228
$68.27 P/Share
|
|
Nov 08
2023
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
602
-0.36%
|
$40,936
$68.27 P/Share
|
|
Nov 08
2023
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
244
-2.83%
|
$16,592
$68.27 P/Share
|
|
Nov 08
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
190
-1.32%
|
$12,920
$68.27 P/Share
|
|
Nov 08
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
126
-0.89%
|
$8,568
$68.27 P/Share
|
|
Nov 07
2023
|
Jan Verstreken Group President, International |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-0.31%
|
$16,796
$68.37 P/Share
|
|
Nov 07
2023
|
Stephen P Macmillan Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,974
-0.31%
|
$270,232
$68.37 P/Share
|
|
Nov 07
2023
|
Karleen Marie Oberton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
740
-0.6%
|
$50,320
$68.37 P/Share
|
|
Nov 07
2023
|
Essex D Mitchell Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-4.36%
|
$26,112
$68.37 P/Share
|
|
Nov 07
2023
|
Jennifer M Schneiders President, Diag. Solutions |
SELL
Payment of exercise price or tax liability
|
Direct |
154
-4.65%
|
$10,472
$68.37 P/Share
|
|
Nov 07
2023
|
John M. Griffin General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
592
-0.35%
|
$40,256
$68.37 P/Share
|
|
Nov 07
2023
|
Elisabeth A Hellmann SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
272
-3.06%
|
$18,496
$68.37 P/Share
|
|
Nov 07
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
SELL
Payment of exercise price or tax liability
|
Direct |
343
-3.07%
|
$23,324
$68.37 P/Share
|
|
Nov 07
2023
|
Benjamin Jordan Cohn Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
106
-0.73%
|
$7,208
$68.37 P/Share
|
|
Nov 06
2023
|
Jan Verstreken Group President, International |
BUY
Grant, award, or other acquisition
|
Direct |
2,438
+2.93%
|
-
|
|
Nov 06
2023
|
Stephen P Macmillan Chairman, President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
24,133
+1.86%
|
-
|
|
Nov 06
2023
|
Karleen Marie Oberton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,633
+3.64%
|
-
|
|
Nov 06
2023
|
Essex D Mitchell Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,463
+14.25%
|
-
|
|
Nov 06
2023
|
John M. Griffin General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,145
+2.38%
|
-
|
|
Nov 06
2023
|
Erik S Anderson Div. Pres., Breast & Skeletal |
BUY
Grant, award, or other acquisition
|
Direct |
853
+7.1%
|
-
|